HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics ; volume:7 ; number:1 ; day:6 ; month:2 ; year:2019 ; pages:1-16 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (6.2.2019), 1-16, 12.2019
- Urheber
-
Laino, Andressa S.
Betts, B. C.
Veerapathran, A.
Dolgalev, I.
Sarnaik, A.
Quayle, S. N.
Jones, S. S.
Weber, J. S.
Woods, David M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0517-0
- URN
-
urn:nbn:de:101:1-2019031123330213104649
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Laino, Andressa S.
- Betts, B. C.
- Veerapathran, A.
- Dolgalev, I.
- Sarnaik, A.
- Quayle, S. N.
- Jones, S. S.
- Weber, J. S.
- Woods, David M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1
Modulation of CAR-LCK engagement to augment the anti-tumor function of genetically engineered T-cells
MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity
Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model
As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction
Selektive HDAC6-Inhibitoren: Synthese und biologische Testung
Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1
Modulation of CAR-LCK engagement to augment the anti-tumor function of genetically engineered T-cells
MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity
Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model
As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction
Selektive HDAC6-Inhibitoren: Synthese und biologische Testung
Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1
Modulation of CAR-LCK engagement to augment the anti-tumor function of genetically engineered T-cells
MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity
Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model
As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction